Lion Point Capital
Latest statistics and disclosures from Lion Point Capital's latest quarterly 13F-HR filing:
- Top 5 stock holdings are MIST, PRAX, MLTX, FENC, JSPR, and represent 28.17% of Lion Point Capital's stock portfolio.
- Added to shares of these 10 stocks: CUE, SRPT, HUMA, VTYX, LNTH, DYN, QURE, PCRX, VTRS, BHVN.
- Started 15 new stock positions in INVA, EWTX, GHRS, LNTH, PCRX, QURE, SRPT, CUE, VTRS, JANX. VTYX, IPHA, DYN, AZTA, NERV.
- Reduced shares in these 10 stocks: MLYS, AVDL, KNSA, INSM, ARQT, MRSN, BBIO, RGNX, SNDX, PRAX.
- Sold out of its positions in INSM, AVDL, KNSA.
- Lion Point Capital was a net seller of stock by $-1.7M.
- Lion Point Capital has $19M in assets under management (AUM), dropping by 9.78%.
- Central Index Key (CIK): 0001643354
Tip: Access up to 7 years of quarterly data
Positions held by Lion Point Capital consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Lion Point Capital
Lion Point Capital holds 39 positions in its portfolio as reported in the December 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Milestone Pharmaceuticals (MIST) | 7.9 | $1.5M | +14% | 755k | 2.02 |
|
| Praxis Precision Medicines I Com New (PRAX) | 6.8 | $1.3M | -21% | 4.5k | 294.74 |
|
| Moonlake Immunotherapeutics Class A Ord (MLTX) | 4.6 | $890k | 68k | 13.18 |
|
|
| Fennec Pharmaceuticals (FENC) | 4.5 | $866k | -8% | 112k | 7.70 |
|
| Jasper Therapeutics Com New (JSPR) | 4.4 | $851k | +16% | 465k | 1.83 |
|
| Benitec Biopharma Com New (BNTC) | 4.3 | $835k | 62k | 13.47 |
|
|
| Royalty Pharma Shs Class A (RPRX) | 4.3 | $827k | 21k | 38.64 |
|
|
| Geron Corporation (GERN) | 3.9 | $763k | +15% | 578k | 1.32 |
|
| Syndax Pharmaceuticals (SNDX) | 3.9 | $756k | -34% | 36k | 21.01 |
|
| Ardelyx (ARDX) | 3.9 | $750k | -20% | 129k | 5.83 |
|
| Cue Biopharma (CUE) | 3.5 | $673k | NEW | 2.2M | 0.31 |
|
| Disc Medicine (IRON) | 3.3 | $643k | -23% | 8.1k | 79.41 |
|
| Sarepta Therapeutics (SRPT) | 3.2 | $613k | NEW | 29k | 21.52 |
|
| Biohaven (BHVN) | 3.0 | $584k | +127% | 52k | 11.29 |
|
| Humacyte (HUMA) | 2.5 | $480k | +498% | 500k | 0.96 |
|
| Kura Oncology (KURA) | 2.5 | $478k | 46k | 10.39 |
|
|
| Seres Therapeutics Com New (MCRB) | 2.4 | $470k | +16% | 32k | 14.88 |
|
| Compass Pathways Sponsored Ads (CMPS) | 2.1 | $400k | 58k | 6.90 |
|
|
| Day One Biopharmaceuticals I (DAWN) | 2.0 | $391k | 42k | 9.32 |
|
|
| Regenxbio Inc equity us cm (RGNX) | 2.0 | $383k | -53% | 27k | 14.40 |
|
| Bridgebio Pharma (BBIO) | 2.0 | $383k | -62% | 5.0k | 76.49 |
|
| Mineralys Therapeutics (MLYS) | 2.0 | $381k | -73% | 11k | 36.29 |
|
| Ventyx Biosciences (VTYX) | 1.9 | $375k | NEW | 42k | 9.03 |
|
| Lantheus Holdings Inc Common Stock Usd 0.01 (LNTH) | 1.9 | $366k | NEW | 5.5k | 66.55 |
|
| Dyne Therapeutics (DYN) | 1.8 | $352k | NEW | 18k | 19.56 |
|
| Uniqure Nv SHS (QURE) | 1.8 | $352k | NEW | 15k | 23.93 |
|
| Pacira Pharmaceuticals (PCRX) | 1.8 | $349k | NEW | 14k | 25.88 |
|
| Viatris (VTRS) | 1.8 | $345k | NEW | 28k | 12.45 |
|
| Brooks Automation (AZTA) | 1.7 | $323k | NEW | 9.7k | 33.26 |
|
| Rocket Pharmaceuticals (RCKT) | 1.6 | $302k | 86k | 3.51 |
|
|
| Janux Therapeutics (JANX) | 1.4 | $262k | NEW | 19k | 13.80 |
|
| Edgewise Therapeutics (EWTX) | 1.2 | $226k | NEW | 9.1k | 24.82 |
|
| Innoviva (INVA) | 0.8 | $164k | NEW | 8.2k | 19.99 |
|
| Arcutis Biotherapeutics (ARQT) | 0.8 | $153k | -85% | 5.3k | 29.04 |
|
| Innate Pharma S A Sponsored Ads (IPHA) | 0.7 | $142k | NEW | 81k | 1.75 |
|
| Minerva Neurosciences Com New (NERV) | 0.7 | $141k | NEW | 35k | 4.02 |
|
| Gh Research Ordinary Shares (GHRS) | 0.7 | $130k | NEW | 10k | 12.70 |
|
| Spruce Biosciences Com New (SPRB) | 0.5 | $87k | 1.0k | 87.11 |
|
|
| Mersana Therapeutics (MRSN) | 0.0 | $2.9k | -99% | 100.00 | 28.93 |
|
Past Filings by Lion Point Capital
SEC 13F filings are viewable for Lion Point Capital going back to 2015
- Lion Point Capital 2025 Q4 filed Feb. 17, 2026
- Lion Point Capital 2025 Q3 filed Nov. 14, 2025
- Lion Point Capital 2025 Q2 filed Aug. 14, 2025
- Lion Point Capital 2025 Q1 filed May 15, 2025
- Lion Point Capital 2024 Q4 filed Feb. 14, 2025
- Lion Point Capital 2024 Q3 filed Nov. 14, 2024
- Lion Point Capital 2024 Q2 filed Aug. 14, 2024
- Lion Point Capital 2024 Q1 filed May 15, 2024
- Lion Point Capital 2023 Q4 filed Feb. 14, 2024
- Lion Point Capital 2023 Q3 filed Nov. 14, 2023
- Lion Point Capital 2023 Q2 filed Aug. 14, 2023
- Lion Point Capital 2023 Q1 filed May 15, 2023
- Lion Point Capital 2022 Q4 filed Feb. 14, 2023
- Lion Point Capital 2022 Q3 filed Nov. 14, 2022
- Lion Point Capital 2022 Q2 filed Aug. 15, 2022
- Lion Point Capital 2022 Q1 filed May 16, 2022